Navigation Links
BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
Date:8/19/2007

in

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio is comprised of two approved products and multiple clinical and preclinical product candidates. Approved products include Naglazyme(R) (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin, and Aldurazyme(R) (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation. Investigational product candidates include Kuvan(TM) (sapropterin dihydrochloride), a Phase 3 product candidate for the treatment of phenylketonuria (PKU), and 6R-BH4 for cardiovascular indications, which is currently in Phase 2 clinical development for the treatment of peripheral arterial disease and sickle cell disease. Both products are being developed in partnership with Merck Serono, a division of Merck KgA of Darmstadt, Germany. For additional information, please visit http://www.BMRN.com. Information on BioMarin's website is not incorporated by reference into this press release.

About AnGes MG, Inc.

AnGes MG, Inc., a biopharmaceutical company founded in 1999, was established on an innovative discovery by researchers of Osaka University. The company specializes in research, development and practical application of genetic medicine. Current programs include the Hepatocyte Growth Factor (HGF) genetic medicine which improves blood circulation by regenerating blood vessels, and an NFkB decoy that controls various types of inflammation.

Forward-Looking Statement

This press release contains forward-looking statements about the business prospects of BioMarin Pharmaceutical Inc., including, without limitation, statements about: the potential approval of Naglazyme in Japan; the continued clinical development and commercialization of Naglazyme; actions
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related medicine technology :

1. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
2. GenoLogics Announces Bioinformatics Partnership with Illumina
3. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care
4. AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results for Anti-Cancer Compound Perifosine at ASCO Meeting
5. AEterna Zentaris Partner, Spectrum, Discloses Detailed Phase 2 Data for Ozarelix, in BPH at Annual AUA Meeting
6. Inovio Biomedicals Partners to Present New Data from Two Cancer Immunotherapy Clinical Trials
7. Catalyst Pharmaceutical Partners, Inc. Announces Top-Line Results of Its Bioequivalence Study of CPP-109 (Vigabatrin), the Companys Investigational Drug to Treat Cocaine and Methamphetamine Addiction
8. Vical Licensee AnGes MG Announces Positive Results of Phase 3 Angiogenesis Trial in Japan
9. KineMed Presents Data Measuring Changes in Reverse Cholesterol Transport for the First Time
10. First Controlled Large-Scale Intervention Angiotensin Receptor Blocker (ARB) Trial in a Japanese Population, JIKEI HEART Study Demonstrates Significant Reduction in Blood Pressure and Protection of Organs with Valsartan
11. AEterna Zentaris Reports Positive Results with Cetrorelix in BPH for Japanese Phase 2a Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... WALTHAM, Mass. , Nov. 21, 2014  Alere ... in rapid diagnostic tests, has appointed Juliet Cunningham ... created role, Cunningham will be responsible for driving communications ... to execute on a series of changes to increase ... our progress to investors," said Namal Nawana, Chief Executive ...
(Date:11/21/2014)...   Rock Creek Pharmaceuticals, Inc., (NASDAQ: ... to present at the Biotech Showcase™ 2015 taking place ... January 12-14, 2015. Michael Mullan ... Pharmaceuticals, will present preclinical and clinical data for anatabine ... pharmacological characteristics. Dr. Mullan will outline the Company,s regulatory ...
(Date:11/21/2014)... 21. November 2014 ... bekannt gegeben, dass die Europäische Arzneimittel-Agentur ... Kennzeichnung als Orphan-Medizinprodukt an Palovarotene vergeben ... zur Behandlung von Fibrodysplasia ossificans progressiva ... beeinträchtigende genetische Krankheit, die von schmerzhaften, ...
Breaking Medicine Technology:Alere Appoints Juliet Cunningham to Lead Investor Relations 2Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 2Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 3Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 4Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 2Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 3
(Date:11/22/2014)... The topic of B&D Rockeries’ latest ... walls. The article states that, “While they give off the ... that go into creating this powerful look.” , One of ... is choosing which kind of block matches your home environment ... says, “The two main options are concrete and stone blocks. ...
(Date:11/22/2014)... 2014 This month has been a historical ... has received many positive reviews from some renowned review websites. ... products by launching a new selection of wonderful sexy wedding ... can enjoy free shipping and up to an 80% discount ... can always find the most suitable dress at Angeldress.co.uk, which ...
(Date:11/22/2014)... Recently, UWDress.com is gratified to introduce ... . In addition, the company has also offered an ... a leading online supplier of wedding dresses, UWDress.com is ... unusual best wedding guest gowns are provided over 20 ... this new selection is famous for high quality. Therefore, ...
(Date:11/22/2014)... Eugene, OR (PRWEB) November 22, 2014 The ... addition of Roy Baroff to its team of ... lawyer, mediator, soccer player, coach, and referee. He has over ... North Carolina and beyond. , “I'm very excited to connect ... experience and sports related interests to a program with a ...
(Date:11/22/2014)... Calif. (PRWEB) November 22, 2014 ... applications was announced today which safely detects and ... high frequency radio waves. Developed by RHT SpectraSafe, ... and hosts broad applications in other areas including ... to security. , Using high frequency radio waves ...
Breaking Medicine News(10 mins):Health News:5 Step Installment of Block Retaining Walls is Topic of Latest Article by B&D Rockeries 2Health News:Sexy Wedding Dresses with Special Discounts Launched by Angeldress.co.uk 2Health News:Best Wedding Guest dresses Introduced by UWDress.com 2Health News:SCI Announces New Team Member Roy Baroff 2Health News:SCI Announces New Team Member Roy Baroff 3Health News:RHT SpectraSafe announces a Radical New Airport Security Technology that Is More Effective, Less Invasive 2
... Top dentist, LA ... , ... 22, 2010 -- Leading cosmetic dentist in Los Angeles, Dr. Katherine Galina, and her staff ... Galina for an exam, X-rays and cleaning appointment and are interested in teeth whitening can ...
... ... ... , , ... ...
... , ... ... , , ... ...
... ... ... ... ...
... Academy at the University of Gothenburg, Sweden and Karolinska ... genetic patterns of neuroblastoma, an aggressive form of childhood ... the treatment of this malignant disease, which mainly affects ... the respected scientific journal, Proceedings of the National ...
... Probably. However, marine biologist ,Helen Nilsson Skld at the ... the spotted insides of plaice. Many species of ... which they use for camouflage, communication, regulation of ,body ... by ,researchers at the Department of Marine Ecology at ...
Cached Medicine News:Health News:LA Dentist, Dr. Katherine Galina, Offers Free Bleaching for Life 2Health News:Statewide Poll: Pennsylvania Must Adequately Fund Senior Care Services 2Health News:Statewide Poll: Pennsylvania Must Adequately Fund Senior Care Services 3Health News:Pelosi Statement on President Obama's Health Insurance Reform Proposal 2Health News:International Merchant Advisors CEO Mel Roseman to Discuss New Medical Marijuana Clinics Live on CBS Radio Network's Big Biz Show February 22, 2010 at 1:40 pm PST 2Health News:International Merchant Advisors CEO Mel Roseman to Discuss New Medical Marijuana Clinics Live on CBS Radio Network's Big Biz Show February 22, 2010 at 1:40 pm PST 3Health News:International Merchant Advisors CEO Mel Roseman to Discuss New Medical Marijuana Clinics Live on CBS Radio Network's Big Biz Show February 22, 2010 at 1:40 pm PST 4Health News:New DNA technique leads to a breakthrough in child cancer research 2
... designed to create the ideal environment for nucleic ... 99.9C) , Variable speed control (10 to ... it be for washing or hybridizing , ... inside the chamber, ,is situated above a touch ...
... designed with a variety of motion options ... in one unit. Shake, rock, roll and ... allow for hybridization and blotting procedures requiring ... The upper chamber uses a roller action ...
... with circular clear acrylic chamber for complete ... Oven features microprocessor operation for precise mixing ... unit., Carousel rotates at 11 rpm; ... removable , Bottle Capacity - four ...
... Minidizer is a personal desktop unit ideal for ... requirements. , Rotation speed set at 12 ... 80o C , Bottle capacity of four ... 15 ml conical ,plastic bottles , Consistent, ...
Medicine Products: